Literature DB >> 15823082

How does a cell repair damaged DNA?

N P Sharova1.   

Abstract

DNA in living cells is constantly subjected to different chemical and physical factors of the environment and to cell metabolites. Some changes altering DNA structure occur spontaneously. This raises the potential danger of harmful mutations that could be transmitted to offspring. To avoid the danger of mutations and changing genetic information, a cell is capable to switch on multiple mechanisms of DNA repair that remove damage and restore native structure. In many cases, removal of the same damage may involve several alternative pathways; this is very important for DNA repair under the most unfavorable conditions. This review summarizes data about all known mechanisms of eukaryotic DNA repair including excision repair (base excision repair and nucleotide excision repair), mismatch repair, repair of double-strand breaks, and cross-link repair. Special attention is given to the regulation of excision repair by different proteins--proliferating cell nuclear antigen (PCNA), p53, and proteasome. The review also highlights problem of bypassing irremovable lesions in DNA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823082     DOI: 10.1007/s10541-005-0113-4

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  4 in total

1.  Synthesis and antiviral activity of 5-substituted cytidine analogues: identification of a potent inhibitor of viral RNA-dependent RNA polymerases.

Authors:  Daniel A Harki; Jason D Graci; Jessica E Galarraga; William J Chain; Craig E Cameron; Blake R Peterson
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

Review 2.  Advances in using PARP inhibitors to treat cancer.

Authors:  Shivaani Kummar; Alice Chen; Ralph E Parchment; Robert J Kinders; Jay Ji; Joseph E Tomaszewski; James H Doroshow
Journal:  BMC Med       Date:  2012-03-09       Impact factor: 8.775

3.  Blocking PARP activity with the inhibitor veliparib enhances radiotherapy sensitivity in endometrial carcinoma.

Authors:  Jing Wang; Weizhen Xing; Yanling Lin; Nuray Uskenbayeva; Hongchao Yan; Yang Xu; Lisha Fang
Journal:  J Clin Lab Anal       Date:  2022-04-14       Impact factor: 3.124

4.  A hybrid machine learning-based method for classifying the Cushing's Syndrome with comorbid adrenocortical lesions.

Authors:  Jack Y Yang; Mary Qu Yang; Zuojie Luo; Yan Ma; Jianling Li; Youping Deng; Xudong Huang
Journal:  BMC Genomics       Date:  2008       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.